Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data.

Hasan Çağın Lenk Robert Løvsletten Smith Kevin Sean O'Connell Ole Andreas Andreassen Espen Molden

Published in: CNS drugs (2024)

LCD and associated rapid metabolism of non-clozapine antipsychotics is frequent before starting clozapine treatment. For olanzapine and quetiapine, this is associated with significantly increased risk of having subtherapeutic concentrations.

Keyphrases

machine learning
big data
combination therapy
smoking cessation